The analysis of the Global Share of Corresponding/Leading Author in Scientific Publications in Oncology by Country, based on 2023 data, reveals that Indonesia leads with a 99.09% share, followed closely by Japan and Russia. Developed countries like the United States and Germany lag slightly behind emerging markets but maintain strong positions. There is a notable decline as we move towards Western Europe, with the UK and smaller nations like Luxembourg having lower shares. While 2024 forecasts minimal changes, the consistent positioning of countries highlights stability in this metric across most regions.
Looking forward, potential trends to watch include shifts due to increasing international collaborations, which could affect lead authorship distribution, particularly in global hubs like the UK, Switzerland, and the Netherlands. Additionally, an emerging emphasis on interdisciplinary research could also influence author shares as oncological studies diversify.
Top countries in Share of Corresponding/Leading Author in Scientific Publications in Oncology by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Indonesia | 99.09 | 2023 | View data |
| 2 | 2 Japan | 97.38 | 2023 | View data |
| 3 | 3 Russia | 97.25 | 2023 | View data |
| 4 | 4 South Korea | 97.07 | 2023 | View data |
| 5 | 5 India | 96.46 | 2023 | View data |
| 6 | 6 Lithuania | 96.29 | 2023 | View data |
| 7 | 7 Kazakhstan | 95.66 | 2023 | View data |
| 8 | 8 Poland | 95.05 | 2023 | View data |
| 9 | 9 United States | 94.86 | 2023 | View data |
| 10 | 10 Czech Republic | 94.15 | 2023 | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...